Journal article

Validation of the PredAHT-2 prediction tool for abusive head trauma

Helena Pfeiffer, Laura Elizabeth Cowley, Alison Mary Kemp, Stuart R Dalziel, Anne Smith, John Alexander Cheek, Meredith L Borland, Sharon O'Brien, Megan Bonisch, Jocelyn Neutze, Ed Oakley, Louise M Crowe, Stephen Hearps, Mark D Lyttle, Silvia Bressan, Franz E Babl

Emergency Medicine Journal | BMJ PUBLISHING GROUP | Published : 2020


OBJECTIVE: The validated Predicting Abusive Head Trauma (PredAHT) clinical prediction tool calculates the probability of abusive head trauma (AHT) in children <3 years of age who have sustained intracranial injuries (ICIs) identified on neuroimaging, based on combinations of six clinical features: head/neck bruising, seizures, apnoea, rib fracture, long bone fracture and retinal haemorrhages. PredAHT version 2 enables a probability calculation when information regarding any of the six features is absent. We aimed to externally validate PredAHT-2 in an Australian/New Zealand population. METHODS: This is a secondary analysis of a prospective multicentre study of paediatric head injuries conduc..

View full abstract


Awarded by National Health and Medical Research Council, Canberra, Australia

Awarded by National Health and Medical Research Council (Centre of Research Excellence for Paediatric Emergency Medicine) Canberra, Australia

Awarded by Emergency Medicine Foundation, Brisbane, Australia

Awarded by Perpetual Philanthropic Services, Australia

Awarded by Auckland Medical Research Foundation, Auckland, New Zealand

Awarded by Health Research Council of New Zealand

Funding Acknowledgements

The study was funded by grants from the National Health and Medical Research Council (project grant GNT1046727, Centre of Research Excellence for Paediatric Emergency Medicine GNT1058560), Canberra, Australia; the Murdoch Children's Research Institute, Melbourne, Australia; the Emergency Medicine Foundation (EMPJ-11162), Brisbane, Australia; Perpetual Philanthropic Services (2012/1140), Australia; Auckland Medical Research Foundation (No. 3112011) and the A + Trust (Auckland District Health Board), Auckland, New Zealand; WA Health Targeted Research Funds 2013, Perth, Australia; the Townsville Hospital and Health Service Private Practice Research and Education Trust Fund, Townsville, Australia; and supported by the Victorian Government's Infrastructure Support Program, Melbourne, Australia. FEB's time was part funded by a grant from the Royal Children's Hospital Foundation and the Melbourne Campus Clinician Scientist Fellowship, Melbourne, Australia, and an NHMRC Practitioner Fellowship, Canberra, Australia. SD's time was part funded by the Health Research Council of New Zealand (HRC13/556).